Entheos Bio is building a sustainable, scalable, technology-facilitated data-driven clinical care model that helps advance our understanding of psychedelic compounds, as well as the biological, psychological, and environmental variables that contribute to treatment outcomes.
Beyond healthcare, the company is building a technology-enabled ecosystem to support clinical psychedelic treatment with intention through a universally accessible system. The company is also developing educational materials and programs designed to build, educate, and manage a clinical workforce, patients and wide array of stakeholders.